Selective ablation of retinoblastoma protein function by the RET finger protein

被引:43
作者
Krützfeldt, M
Ellis, M
Weekes, DB
Bull, JJ
Eilers, M
Vivanco, MDM
Sellers, WR
Mittnacht, S
机构
[1] Chester Beatty Labs, Inst Canc Res, Ctr Cell & Mol Biol, London SW3 6JB, England
[2] Chester Beatty Labs, Inst Canc Res, Breakthrough Ctr, London SW3 6JB, England
[3] Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA 02115 USA
[5] Univ Marburg, Inst Mol Biol & Tumor Res, D-35033 Marburg, Germany
基金
英国医学研究理事会;
关键词
D O I
10.1016/j.molcel.2005.03.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The retinoblastoma tumor suppressor protein (Rb) affects gene transcription both negatively and positively and through this regulates distinct cellular responses. Although cell cycle regulation requires gene repression, Rb's ability to promote differentiation and part of its anti proliferative activity appears to rely on the activation of gene transcription. We present evidence here that the RET finger protein (RFP)/tripartite motif protein 27 (TRIM 27) inhibits gene transcription activation by Rb but does not affect gene repression. RFP binds to Rb and prevents the degradation of the EID-1 inhibitor of histone acetylation and differentiation. Furthermore, ablation of RFP in U2OS osteosarcoma cells augments a transcriptional program indicative of lineage-specific differentiation in response to Rb. These findings provide precedent for a regulatory pathway that uncouples different Rb-dependent activities and thus silences specific cellular responses to Rb in a selective way.
引用
收藏
页码:213 / 224
页数:12
相关论文
共 42 条
[1]   The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein [J].
Alcalay, M ;
Tomassoni, L ;
Colombo, E ;
Stoldt, S ;
Grignani, F ;
Fagioli, M ;
Szekely, L ;
Helin, K ;
Pelicci, PG .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (02) :1084-1093
[2]   DEFICIENCY OF RETINOBLASTOMA PROTEIN LEADS TO INAPPROPRIATE S-PHASE ENTRY, ACTIVATION OF E2F-RESPONSIVE GENES, AND APOPTOSIS [J].
ALMASAN, A ;
YIN, YX ;
KELLY, RE ;
LEE, EYHP ;
BRADLEY, A ;
LI, WW ;
BERTINO, JR ;
WAHL, GM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) :5436-5440
[3]   A transcriptional inhibitor targeted by the atypical orphan nuclear receptor SHP [J].
Båvner, A ;
Johansson, L ;
Toresson, G ;
Gustafsson, JÅ ;
Treuter, E .
EMBO REPORTS, 2002, 3 (05) :478-484
[4]   Retinoblastoma protein-mediated apoptosis after γ-irradiation [J].
Bowen, C ;
Birrer, M ;
Gelmann, EP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (47) :44969-44979
[5]   RB activation defect in tumor cell lines [J].
Broceño, C ;
Wilkie, S ;
Mittnacht, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (22) :14200-14205
[6]  
Cao TY, 1998, J CELL SCI, V111, P1319
[7]  
Cao TY, 1996, DEV GENET, V19, P309, DOI 10.1002/(SICI)1520-6408(1996)19:4<309::AID-DVG4>3.0.CO
[8]  
2-D
[9]   pRB phosphorylation mutants reveal role of pRB in regulating S phase completion by a mechanism independent of E2F [J].
Chew, YP ;
Ellis, M ;
Wilkie, S ;
Mittnacht, S .
ONCOGENE, 1998, 17 (17) :2177-2186
[10]   Identification of ErbB3-stimulated genes using modified representational difference analysis [J].
Edman, CF ;
Prigent, SA ;
Schipper, A ;
Feramisco, JR .
BIOCHEMICAL JOURNAL, 1997, 323 :113-118